Effects of Subchronic Buspirone Treatment on Depressive Profile in Socially Isolated Rats: Implication of Early Life Experience on 5-HT1A Receptor-Related Depression
Open Access
- 1 June 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (6) , 717
Abstract
The heterogeneity of etiology may serve as a crucial factor in the challenges of treatment, including the low response rate and the delay in establishing therapeutic effect. In the present study, we examined whether social experience since early life is one of the etiologies, with the involvement of the 5-HT1A receptors, and explored the potentially therapeutic action of the subchronic administration of buspirone, a partial 5-HT1A agonist. Rats were isolation reared (IR) since their weaning, and the depressive profile indexed by the forced-swim test (FST) was examined in adulthood. Nonspecific locomotor activity was used for the IR validation. Buspirone administration (1 mg/kg/day) was introduced for 14 days (week 9–11). The immobility score of the FST was examined before and after the buspirone administration. Tissue levels of serotonin (5-HT) and its metabolite 5-HIAA were measured in the hippocampus, the amygdala, and the prefrontal cortex. Efflux levels of 5-HT, dopamine (DA), and norepinephrine (NE) were detected in the hippocampus by brain dialysis. Finally, the full 5-HT1A agonist 8-OH-DPAT (0.5 mg/kg) was acutely administered in both behavioral testing and the dialysis experiment. Our results showed (i) increased immobility time in the FST for the IR rats as compared to the social controls, which could not be reversed by the buspirone administration; (ii) IR-induced FST immobility in rats receiving buspirone was corrected by the 8-OH-DPAT; and (iii) IR-induced reduction in hippocampal 5-HT levels can be reversed by the buspirone administration. Our data indicated the 5-HT1A receptor-linked early life social experience as one of the mechanisms of later life depressive mood.Keywords
Funding Information
- National Science and Technology Council (NSTC 112-2410-H-350-001, MOST 111-2410-H-350-001, CH-NDMC-108-9, CH-NDMC-109-7, CH-NDMC-110-9, CH-NDMC-111-09)
- Ministry of Science and Technology, Israel (NSTC 112-2410-H-350-001, MOST 111-2410-H-350-001, CH-NDMC-108-9, CH-NDMC-109-7, CH-NDMC-110-9, CH-NDMC-111-09)
- Cheng Hsin General Hospital and National Defense Medical Center (NSTC 112-2410-H-350-001, MOST 111-2410-H-350-001, CH-NDMC-108-9, CH-NDMC-109-7, CH-NDMC-110-9, CH-NDMC-111-09)
This publication has 44 references indexed in Scilit:
- Reevaluating the Efficacy and Predictability of Antidepressant TreatmentsJAMA Psychiatry, 2017
- Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of ResearchCNS Drugs, 2013
- Regional Variations of 5HT Concentrations in Rora sg (staggerer) MutantsNeurochemical Research, 2006
- Treatment-refractory depression: Definitions and characteristicsDepression and Anxiety, 1997
- The effect of 5-HT1A receptor ligands in a chronic mild stress model of depressionNeuropharmacology, 1995
- Effects of combined or separate 5,7-dihydroxytryptamine lesions of the dorsal and median raphe nuclei on responding maintained by a DRL 20s schedule of food reinforcementBrain Research, 1995
- Effect of isolation rearing on 5-HT agonist-induced responses in the ratPsychopharmacology, 1991
- Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: A comparative study with dorsal raphe neuronsNeuropharmacology, 1988
- Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonistsSynapse, 1987
- Buspirone: Effects on central monoaminergic transmission - possible relevance to animal experimental and clinical findingsEuropean Journal of Pharmacology, 1982